PDF herunterladen
CC BY-NC-ND 4.0 · Journal of Diabetes and Endocrine Practice 2021; 04(02): 64-68
DOI: 10.4103/jdep.jdep_1_21
Original Article

COVID-19 lockdown and hypoglycemia among patients with diabetes fasting the month of Ramadan 2020

Zahra Ghareeb
1   Department of Internal Medicine, Qatif Central Hospital, Qatif, Eastern Province, Saudi Arabia
,
Zainab Saffar
1   Department of Internal Medicine, Qatif Central Hospital, Qatif, Eastern Province, Saudi Arabia
,
Ghadeer Ghareeb
2   Department of Qatif Public Health, Qatif Primary Health Care Centers, Qatif, Eastern Province, Saudi Arabia
,
Ghalia Almaalu
1   Department of Internal Medicine, Qatif Central Hospital, Qatif, Eastern Province, Saudi Arabia
,
Alia Alnaj
2   Department of Qatif Public Health, Qatif Primary Health Care Centers, Qatif, Eastern Province, Saudi Arabia
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Background: Patients with diabetes are targeted with diabetes education 8–10 weeks before Ramadan to have a safe fasting experience. In 2020, this timing coincided with COVID-19 lockdown when virtual clinics were implemented to secure patient care continuity. Objectives: We evaluated hypoglycemia episodes among patients with diabetes fasting in Ramadan 2020 during COVID-19 lockdown. Patients and Methods: A cross-sectional study was conducted after the month of Ramadan 2020, using a self-administered online questionnaire and convenient sampling methods. Patients with diabetes aged 14 years and older who practiced fasting in Ramadan were included in the study. Hypoglycemia rate in total and diabetes treatment among observers of Ramadan 2019 and Ramadan 2020 were compared. Predictors of hypoglycemia during fasting Ramadan 2020 were estimated. Results: Out of 367 patients with diabetes aged 14 years and older, 326 (88.8%) participants had the ability to fast Ramadan and were included in the study. Comparing patients' experience in Ramadan 2019 and Ramadan 2020, participants reported lower hypoglycemia episodes during Ramadan 2020 than Ramadan 2019, P = 0.017. In subgroup analysis based on the type of treatment, patients on noninsulin treatment had statistically significant lower hypoglycemia episodes during Ramadan 2020 than Ramadan 2019 (P = 0.006). Patients on insulin treatment had fewer hypoglycemia episodes during Ramadan 2020 than Ramadan 2019, but the difference was not statistically significant (P = 0.405). The probability of hypoglycemia during fasting Ramadan 2020 was higher among younger age groups 14–30 years (odds ratio [OR] 7.24, 95% confidence interval [CI] 1.72–30.39), patients aged 31–45 years (OR 7.18, 95% CI 1.97–26.19), patients with longer duration of diabetes (more than 10 years) (OR 2.30, 95% CI 1.01–5.26), and patients on insulin (OR 14.14, 95% CI 1.72–30.39). Conclusions: COVID-19 pandemic and lockdown did not affect the diabetes-related experience among participants' fasting Ramadan. The hypoglycemia episodes of patients with diabetes in Saudi Arabia were improved during the pandemic era. This could be related to telemedicine services. More studies are required to support its role in improving health conditions beyond our population's pandemic era.

Keywords

COVID-19 - hypoglycemia - insulin - lockdown - pandemics - telemedicine

Financial support and sponsorship

Nil.




Publikationsverlauf

Eingereicht: 20. Januar 2021

Angenommen: 20. März 2021

Artikel online veröffentlicht:
06. Juli 2022

© 2021. Gulf Association of Endocrinology and Diabetes (GAED). All rights reserved. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed 2020;91:157-60.
  • 2 Atalan A. Is the lockdown important to prevent the COVID-19 pandemic? Effects on psychology, environment and economy-perspective. Ann Med Surg (Lond) 2020;56:38-42.
  • 3 Monaghesh E, Hajizadeh A. The role of telehealth during COVID-19 outbreak: A systematic review based on current evidence. BMC Public Health 2020;20:1193.
  • 4 Simple P, Oswald S, Schwarz PE, Harst L. Mapping the evidence on the effectiveness of telemedicine interventions in diabetes, dyslipidemia, and hypertension: An umbrella review of systematic reviews and meta-analyses. J Med Internet Res 2020;22:e16791.
  • 5 Meo S. COVID-19 pandemic: Saudi Arabia's role at national and international levels. J Diabetes Sci Technol 2020;14:758-9.
  • 6 AlKhaldi YM, AlKhaldi AY, AlQahtani AS, Al-Shahrani BS, Meshawi EA, Albishri BM. Incidence of hypoglycemia and its risk factors among people with diabetes during Ramadan in Abha city, Aseer Region, KSA. J Family Med Prim Care 2019;8:2793-8.
  • 7 Mohamed OM, Hassanein M, Syeed A, Khan FB, Al Tunaiji M, Al Mazrouei S, et al. Impact of pre-Ramadan intervention program on diabetic patients (PRINTED 1): A randomised controlled trial in a family medicine clinic Abu Dhabi. 2019;2019:93594.
  • 8 Tourkmani AM, Hassali MA, Alharbi TJ, Alkhashan HI, Alobikan AH, Bakhiet AH, et al. Impact of Ramadan focused education program on hypoglycemic risk and metabolic control for patients with Type 2 diabetes. Patient Prefer Adherence 2016;10:1709-17.
  • 9 Habiba D. D-NET Connecting Diabetes Professionals Worldwide; 2016. Available from: https://www.d-net.idf.org/en/library/359-dia betes-and-ramadan-practical-guidelines.html. [Last accessed on 2020 Dec 29].
  • 10 Hassanein M. Ramadan focused on diabetes education; a much-needed approach. J Pak Med Assoc 2015;65 Suppl 5:S76-8.
  • 11 Lee JY, Wong CP, Tan CS, Nasir NH, Lee SW. Telemonitoring in fasting individuals with Type 2 Diabetes Mellitus during Ramadan: A prospective, randomized controlled study. Sci Rep 2017;7:10119.
  • 12 Alabbood MH, Ho KW, Simons MR. The effect of Ramadan fasting on glycaemic control in insulin-dependent diabetic patients: A literature review. Diabetes Metab Syndr 2017;11:83-7.
  • 13 UK Hypoglycaemia Study Group. Risk of hypoglycaemia in Types 1 and 2 diabetes: Effects of treatment modalities and their duration. Diabetologia 2007;50:1140-7.
  • 14 Salti I, Bénard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: Results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 2004;27:2306-11.
  • 15 Silbert R, Salcido-Montenegro A, Rodriguez-Gutierrez R, Katabi A, McCoy RG. Hypoglycemia among patients with Type 2 diabetes: Epidemiology, risk factors, and prevention strategies. Curr Diab Rep 2018;18:53.
  • 16 Rashid F, Abdelgadir E, Bashier A. A systematic review of the safety of Ramadan fasting in high-risk patients with diabetes. Diabetes Res Clin Pract 2020;164:108161.